Virios Therapeutics (VIRI) Stock Chart & Stock Price History $4.80 -0.05 (-1.03%) As of 08/13/2025 Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsHeadlinesInsider TradesOptions ChainSEC FilingsTrendsBuy This Stock Virios Therapeutics Stock Price Performance The Virios Therapeutics (VIRI) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 2,635.04%, with a year-to-date return of 68.42%. In the past month, the stock has increased 0.84%, reflecting recent market activity. As of the latest close, Virios Therapeutics traded at $4.85 with a market cap of $93.40 million and volume of 18,558 shares. Receive VIRI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Virios Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-1.88%1 Month Performance+0.84%3 Month Performance-1.03%Year-To-Date Performance+68.42%1 Year Performance+2,635.04% VIRI Stock Chart for Thursday, August, 14, 2025 VIRI Chart by TradingView Virios Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/14/2025$4.85$4.80-1.03%$4.96$4.6812,813 shs$92.44 million08/13/2025$4.77$4.85+1.68%$4.94$4.7118,558 shs$93.40 million08/12/2025$4.89$4.77-2.45%$4.89$4.767,788 shs$91.86 million08/11/2025$4.89$4.89$4.99$4.7611,807 shs$94.17 million08/08/2025$4.87$4.89+0.55%$5.08$4.7531,130 shs$94.21 million08/07/2025$4.87$4.87$4.95$4.838,989 shs$93.69 million08/06/2025$4.86$4.87+0.10%$4.95$4.838,989 shs$93.69 million08/05/2025$4.85$4.86+0.21%$4.93$4.858,162 shs$93.59 million08/04/2025$4.85$4.85$4.89$4.794,239 shs$93.40 million08/01/2025$4.87$4.84-0.72%$4.94$4.767,725 shs$93.11 million Get the Latest News and Ratings for VIRI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Virios Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/31/2025$4.82$4.87+1.04%$5.07$4.7228,481 shs$93.79 million07/30/2025$4.82$4.82$4.90$4.759,847 shs$92.82 million07/29/2025$4.77$4.82+1.05%$4.90$4.759,847 shs$92.82 million07/28/2025$4.77$4.77$4.89$4.7510,492 shs$91.86 million07/25/2025$4.82$4.73-1.87%$4.88$4.707,088 shs$91.09 million07/24/2025$4.69$4.82+2.77%$4.82$4.6911,765 shs$92.82 million07/23/2025$4.83$4.69-2.90%$4.80$4.6034,047 shs$90.32 million07/22/2025$4.83$4.83$4.90$4.7516,126 shs$93.02 million07/21/2025$4.83$4.83$4.90$4.7516,126 shs$93.02 million07/18/2025$4.50$4.76+5.78%$4.90$4.5223,193 shs$91.67 million07/17/2025$4.70$4.50-4.26%$4.80$4.5047,170 shs$86.66 million07/16/2025$5.08$4.70-7.48%$5.12$4.6459,460 shs$90.51 million07/15/2025$4.76$5.08+6.72%$5.08$4.7331,482 shs$97.83 million07/14/2025$4.76$4.76$4.95$4.7131,531 shs$91.67 million Related Companies MBX Biosciences Stock Price Chart Compass Therapeutics Stock Price Chart Esperion Therapeutics Stock Price Chart Astria Therapeutics Stock Price Chart Nanobiotix Stock Price Chart Fulcrum Therapeutics Stock Price Chart Inventiva Stock Price Chart Tonix Pharmaceuticals Stock Price Chart Aura Biosciences Stock Price Chart Arcturus Therapeutics Stock Price Chart Receive VIRI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Virios Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VIRI) was last updated on 8/14/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virios Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Virios Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access